Skip to main content
. 2021 Feb 19;27(6):869–875. doi: 10.1016/j.jiac.2021.02.019

Fig. 1.

Fig. 1

Prevalence of any thromboembolic events and prophylactic anticoagulation therapy in each category of severity for COVID-19

∗Severity of disease was categorized using the Interim Guidance issued by the World Health Organization.